30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: Symmetry Medical

4Q13 revenue: $101.2, -5%

  • Instruments $28.8MM, -4%
  • Implants $26.5MM, flat
  • Cases $16.9MM, +21%
  • Other $6.4MM, -16%
  • Surgical $22.6MM, -21%

 

2013 revenue: $400.0MM, -3%

  • Instruments $112.2MM, -3%
  • Implants $106.7MM, +5%
  • Cases $67.4MM, +15%
  • Other $24.5MM, -11%
  • Surgical $89.2MM, -17%

Other includes non-orthopaedic revenue.

 

  • Noted a backdrop of stable-to-improving orthopaedic procedure volumes
  • Participation in recent new knee platform launches lower than originally targeted in instruments
  • Internal estimates suggest that customer implant inventories are at lowest days-of-supply level in years